Prostate testing may not target those most likely to benefit, warn experts

Current prostate specific antigen (PSA) testing "may not effectively target testing to those most likely to benefit, raising concerns about overtesting" warn researchers from the University of Oxford in a study of over 10 million men across England published by The BMJ .

source https://medicalxpress.com/news/2025-10-prostate-benefit-experts.html